KSHV ORF 62 Antibodies

Santa Cruz Biotechnology delivers a wide array of KSHV ORF 62 monoclonal antibodies for research focused on understanding Kaposi's Sarcoma-associated Herpesvirus (KSHV). KSHV ORF 62 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KSHV ORF 62 functions as a transcriptional activator that regulates the expression of other viral genes. KSHV ORF 62 is essential for viral replication and persistence, making it a significant factor in KSHV-associated malignancies such as Kaposi's sarcoma and primary effusion lymphoma. Research into KSHV ORF 62 continues to reveal new insights about viral mechanisms and potential therapeutic targets. Understanding KSHV ORF 62's role in viral pathogenesis opens new avenues for developing treatments against KSHV-related diseases. Investigating the molecular mechanisms of KSHV ORF 62 helps illuminate viral gene regulation and lifecycle progression. KSHV ORF 62 research supported by Santa Cruz Biotechnology monoclonal antibodies advances scientific understanding of viral pathogenesis and supports the development of new therapeutic strategies.